Literature DB >> 9655314

S. aureus isolation from the lesions, the hands, and the anterior nares of patients with atopic dermatitis.

J V Williams1, B R Vowels, P J Honig, J J Leyden.   

Abstract

Staphylococcus aureus colonization is common in atopic dermatitis (AD) and can exacerbate the disease. Additionally, some evidence shows that patients with AD may act as reservoirs for S. aureus transmission to others. This study compared S. aureus colonization in AD patients and their caregivers with control patients and their caregivers. Quantitative cultures were obtained from the lesions, clinically normal skin, hands, and anterior nares of 100 patients with AD, 100 controls with other cutaneous disorders, and 200 caregivers. AD patients had a significantly greater carriage of S. aureus from lesional and clinically normal skin as well as the hand. Significant increases in carriage of S. aureus were found in the anterior nares and hands of caregivers of AD patients compared with control caregivers. Topical corticosteroid use did not affect recovery of S. aureus. There was a significant correlation between recovery of S. aureus from lesional skin and recovery from the anterior nares (p = .002) and hands (p < .0001). These findings suggest that the anterior nares and the hands may be important reservoirs and vectors for transmission of S. aureus to lesional skin and to close contacts of these patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655314     DOI: 10.1046/j.1525-1470.1998.1998015194.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  8 in total

Review 1.  Atopic dermatitis in children: clinical features, pathophysiology, and treatment.

Authors:  Jonathan J Lyons; Joshua D Milner; Kelly D Stone
Journal:  Immunol Allergy Clin North Am       Date:  2014-11-21       Impact factor: 3.479

Review 2.  Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs.

Authors:  Günter Kampf; Axel Kramer
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

3.  Molecular and immunological characterization of Staphylococcus aureus in pediatric atopic dermatitis: implications for prophylaxis and clinical management.

Authors:  Chiara Pascolini; Jolinda Sinagra; Simone Pecetta; Valentina Bordignon; Alessandra De Santis; Laura Cilli; Viviana Cafiso; Grazia Prignano; Bruno Capitanio; Claudio Passariello; Stefania Stefani; Paola Cordiali-Fei; Fabrizio Ensoli
Journal:  Clin Dev Immunol       Date:  2011-10-27

4.  Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis.

Authors:  Heidi H Kong; Julia Oh; Clay Deming; Sean Conlan; Elizabeth A Grice; Melony A Beatson; Effie Nomicos; Eric C Polley; Hirsh D Komarow; Patrick R Murray; Maria L Turner; Julia A Segre
Journal:  Genome Res       Date:  2012-02-06       Impact factor: 9.043

5.  Change in Antimicrobial Susceptibility of Skin-Colonizing Staphylococcus aureus in Korean Patients with Atopic Dermatitis during Ten-Year Period.

Authors:  Jung-Min Park; Ju-Hyun Jo; Hyunju Jin; Hyun-Chang Ko; Moon-Bum Kim; Jung-Min Kim; Do-Won Kim; Ho-Sun Jang; Byung-Soo Kim
Journal:  Ann Dermatol       Date:  2016-07-26       Impact factor: 1.444

Review 6.  Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility?

Authors:  Kristina M James; R Stokes Peebles; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2012-08       Impact factor: 10.793

Review 7.  Skin Microbiome in Atopic Dermatitis.

Authors:  Sofie M Edslev; Tove Agner; Paal S Andersen
Journal:  Acta Derm Venereol       Date:  2020-06-09       Impact factor: 3.875

8.  Assessment of intralesional cytokine profile of cutaneous leishmaniasis caused by Leishmania donovani in Sri Lanka.

Authors:  Lahiru Sandaruwan Galgamuwa; Buthsiri Sumanasena; Devika Iddawela; Susiji Wickramasinghe; Lalani Yatawara
Journal:  BMC Microbiol       Date:  2019-01-14       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.